1701P Cancer premium: Explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland.
In: Annals of Oncology, Jg. 34 (2023-10-02), S. S929
academicJournal
Zugriff:
Titel: |
1701P Cancer premium: Explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland.
|
---|---|
Autor/in / Beteiligte Person: | Serra-Burriel, M. ; Perényi, G. ; Laube, Y. ; Mitchell, A. ; Vokinger, K.N. |
Zeitschrift: | Annals of Oncology, Jg. 34 (2023-10-02), S. S929 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2023.09.2655 |
Schlagwort: |
|
Sonstiges: |
|